What is the prevalence of ROHHAD?
How many people does ROHHAD affect? Does it have the same prevalence in men and women? And in the different countries?
ROHHAD (Rapid-onset Obesity with Hypothalamic Dysfunction, Hypoventilation, and Autonomic Dysregulation) is an extremely rare and life-threatening syndrome. Due to its rarity, the prevalence of ROHHAD is not well-established. However, it is estimated that there are fewer than 100 reported cases worldwide. This syndrome primarily affects children, and its exact cause is still unknown. Early diagnosis and intervention are crucial for managing the symptoms and improving the quality of life for individuals with ROHHAD.
ROHHAD (Rapid-onset Obesity with Hypothalamic Dysfunction, Hypoventilation, and Autonomic Dysregulation) is an extremely rare and complex pediatric syndrome. Due to its rarity, determining the exact prevalence of ROHHAD is challenging. However, it is estimated that there are approximately 100 known cases worldwide.
ROHHAD primarily affects children between the ages of 2 and 10 years, with symptoms typically appearing suddenly. The condition is characterized by rapid-onset obesity, hypothalamic dysfunction leading to hormonal imbalances, hypoventilation (breathing difficulties), and autonomic dysregulation affecting various bodily functions.
While the prevalence of ROHHAD is low, it is crucial to raise awareness about this condition to ensure early diagnosis and appropriate management. Early detection is vital as ROHHAD can lead to life-threatening complications if left untreated.
Research efforts are ongoing to better understand the underlying causes and develop effective treatments for ROHHAD. Collaborative initiatives between medical professionals, researchers, and families affected by ROHHAD are essential in advancing knowledge and support for this rare syndrome.
